• Noman Khan
• Shalini Kumari

All joint-related conditions are often referred to as having arthritis. The joints in the body, which include the wrists, fingers, toes, hips, and knees, are the places where bones connect. Rheumatic diseases are the general term used to describe these disorders. Unintentionally attacking its own tissues by the immune system is how rheumatoid arthritis, an autoimmune disease, arises. Rheumatoid arthritis affects 0.92% of adult Indians. The primary reasons for the increasing incidence of RA in India are most likely an ageing population, changes in lifestyle, and increased stress levels. Many RA patients may have delayed or inappropriate treatment as a consequence of an incorrect or mistaken diagnosis. Due to the lack of trained medical practitioners with RA specialty in India, patients find it difficult to get specialist therapy. The pathophysiology of RA is largely dependent on genetic predisposition, environmental factors, and cytokines. NSAIDs, Disease-Modifying Anti rheumatic Drugs (DMARDs) such as methotrexate, and biological DMARDs are among the treatment choices available for improved results. In situations of severity, surgical procedures become required. Research advances and treatment improvements are driving growth in the market for RA medications, according to market trends.

Key Words: Autoimmune disease, Prevalence, Biological DMARDs, Patient care, Global Market trend.

"“Rheumatoid Arthritis in India: Epidemiology, Impact, and Care Perspectives"", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 3, page no.f462-f472, March-2025, Available :http://www.jetir.org/papers/JETIR2503583.pdf

"“Rheumatoid Arthritis in India: Epidemiology, Impact, and Care Perspectives"", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 3, page no. ppf462-f472, March-2025, Available at : http://www.jetir.org/papers/JETIR2503583.pdf